Glut-1 was overexpressed in 59% (19/32) of the BRCA1 mutation-related DCIS cases and HIF-1α was co-overexpression in 41% (13/32) of these cases (p = 0.403). Here, SLC2A1 is linked to ductal breast carcinoma in situ.